Surgical staplers market seen reaching $12.58B by 2035

Market Research Future says the global surgical staplers market will grow from $7.14 billion in 2026 to $12.58 billion by 2035, driven by robotic surgery adoption, powered-device conversion and outpatient procedure growth. The forecast points to stronger demand in North America and Asia-Pacific as hospitals and ambulatory centers expand stapler-intensive care.

Why it matters: - Surgical staplers are becoming more central to robotic surgery, minimally invasive procedures and outpatient care. - The market’s growth is tied to structural procedure volume, not discretionary spending. - Rising demand for powered and sensor-equipped devices could affect complication rates, procurement patterns and device pricing across hospitals and ambulatory surgical centers.

What happened: - Market Research Future projected the global Surgical Staplers Market at $12.58 billion by 2035. - The market is forecast to rise from $7.14 billion in 2026, at a 6.50% CAGR from 2026 to 2035. - The market base was estimated at $6.68 billion in 2025. - The report was released June 23, 2026.

The details: - Robotic-assisted procedures crossed 2.1 million globally in 2024, with stapling the highest-consumption accessory category per procedure. - The U.S. added more than 400 da Vinci system installations in 2024. - Each new da Vinci installation is estimated to generate $150,000 to $200,000 in annual stapler consumable spend. - CMS expanded the list of ambulatory surgical center-eligible procedures by 14 orthopedic and gastrointestinal codes in January 2024. - ASCs now perform an estimated 29% of all laparoscopic cholecystectomies in the U.S., up from 18% in 2020. - Linear staplers held about 42.5% of revenue in 2025, making them the dominant product segment. - Laparoscopic staplers are the fastest-growing product category, at 9.52% CAGR from 2026 to 2035. - Manual staplers held about 58.8% of the mechanism market in 2025. - Powered staplers are the fastest-growing mechanism, at 8.04% CAGR. - Disposable staplers accounted for about 75.9% of usability share in 2025. - Reusable staplers are the fastest-growing format, at 7.82% CAGR. - Abdominal and gastrointestinal surgery held about 43.1% of application revenue in 2025. - Orthopedic surgery is the fastest-growing application, at 9.08% CAGR. - Hospitals and clinics held about 76.3% of end-user share in 2025. - Ambulatory surgical centers are the fastest-growing end-user segment, at 8.91% CAGR. - North America held about 42.3% of the market in 2025. - Europe was the second-largest region, at about 28.0% share in 2025. - Asia-Pacific was the fastest-growing region, at 8.97% CAGR from 2026 to 2035. - The Middle East and Africa market was valued at $0.23 billion in 2025. - South America was valued at $0.28 billion in 2025. - The market is moderately concentrated, with an estimated Herfindahl-Hirschman Index of 1,200 to 1,500. - The top five businesses generated an estimated 62% to 68% of revenue. - Johnson & Johnson's Ethicon division held an estimated 20% to 25% of global revenue in 2024-2025. - Medtronic received FDA 510(k) clearance in 2026 for the Signia 2.0 powered stapling platform. - B. Braun Melsungen held an estimated 7% to 10% of revenue in 2024-2025.

Between the lines: - The biggest demand driver is not one procedure type but the spread of robotic platforms, powered devices and outpatient surgery settings that each increase stapler turnover. - The move from manual to powered staplers suggests hospitals are prioritizing consistency and lower complication risk over upfront device cost. - Regional growth patterns show that reimbursement policy, hospital modernization and procedure migration are as important as clinical adoption. - The market remains concentrated at the top, but pooled-procurement and emerging-market segments stay more fragmented and price-sensitive.

What's next: - Market Research Future expects AI-integrated surgical decision support to become a major part of stapling device delivery by 2030. - The report says machine-vision systems in robotic consoles could enable semi-autonomous staple-line placement by 2030. - The forecast says that could reduce procedure times by 15% to 20%. - Sensor-equipped staplers are expected to generate more firing logs, giving hospitals data for quality benchmarking and manufacturers data for compliance and adverse-event tools. - The report also points to more premium demand if audit trails help reduce litigation risk in the U.S.

The bottom line: - Surgical staplers are shifting from commodity surgical tools to data-enabled, robotics-linked devices with recurring consumable revenue and stronger pricing power.